1.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

2.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

3.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

4.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

5.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

6.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

7.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

8.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

9.

Assessment of children’s exposure to currently used pesticides in wallonia, Belgium

1.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

2.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

3.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

4.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

5.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

6.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

7.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

8.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

9.

Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie

1.

Exposure assessment of the Walloon population to pesticides within the BMH-WAL study

2.

Exposure assessment of the Walloon population to pesticides within the BMH-WAL study

3.

Exposure assessment of the Walloon population to pesticides within the BMH-WAL study

4.

Exposure assessment of the Walloon population to pesticides within the BMH-WAL study

1.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

2.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

3.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

4.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

5.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

6.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

7.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

8.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

9.

table1_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

1.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

2.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

3.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

4.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

5.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

6.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

7.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

8.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

9.

table2_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

1.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

2.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

3.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

4.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

5.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

6.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

7.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

8.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

9.

table3_Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.pdf

1.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

2.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

3.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

4.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

5.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

6.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

7.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

8.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

9.

DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF